SCHEMBL16788907

SCHEMBL16788907

CC(C)c1cc(F)c(N2CCN(c3c(F)cccc3F)CC2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TRPV4 Q9HBA0 1/20 0.37
ALDH1A1 P00352 3/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
TP53 P04637 1/20 0.34
MC4R P32245 3/20 0.34
FFAR4 Q5NUL3 1/20 0.34
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MC5R P33032 1/20 0.33
MC3R P41968 1/20 0.33
DRD2 P14416 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16249193 0.92 MAPT (0.37) SLC6A2SLC6A3TRPV4ALDH1A1POLB
SCHEMBL14924079 0.84 MAPT (0.42) TRPV4ALDH1A1MAPTKMT2ALMNA
SCHEMBL16249187 0.81 ALDH1A1 (0.36) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL14137696 0.79 ALDH1A1 (0.41) ALDH1A1POLBMAPTMEN1KMT2A
SCHEMBL21654083 0.79 GAA (0.41) ALDH1A1GAAHSD17B10KDM4E
SCHEMBL20883672 0.79 ALDH1A1 (0.46) ALDH1A1MAPTLMNASMN1; SMN2HTR2A
SCHEMBL18876521 0.78 KDM4E (0.46) SLC6A2SLC6A3ALDH1A1MAPTMC4R
SCHEMBL25964449 0.77 HSD11B1 (0.39) TRPV4ALDH1A1MAPTMEN1KMT2A
SCHEMBL16249188 0.77 SLC18A3 (0.43) DRD2
SCHEMBL16249192 0.77 CA12 (0.43) SLC6A2MEN1KMT2AHTTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150158909-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158909-A1 ANTI-VIRAL COMPOUNDS HAVCR2, EIF2AK2, MAVS SLC6A2 4335/4885SLC6A3 3839/4885TRPV4 3652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.